Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS
· Delayed Price · Currency is USD
0.7510
-0.0400 (-5.06%)
Jul 11, 2025, 1:53 PM EDT
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $3.36 million as of July 11, 2025. Its market cap has decreased by -12.77% in one year.
Market Cap
3.36M
Enterprise Value
-845.95K
Revenue
519.87K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 3.36M, a decrease of -87.60%. That is a compound annual growth rate of -55.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 3.36M | -9.01% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 781.22M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 555.99M |
| Glass House Brands | 536.88M |
| CytoDyn | 398.15M |
| American Oncology Network | 378.82M |